Please login to the form below

Not currently logged in
Email:
Password:

Jivi

This page shows the latest Jivi news and features for those working in and with pharma, biotech and healthcare.

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

The company in the midst of a rollout of its long-acting factor VIII product Jivi (damoctocog alfa pegol).

Latest news

  • Bayer roll-out of haemophilia drug Jivi gathers pace Bayer roll-out of haemophilia drug Jivi gathers pace

    Jivi is another option in an increasingly crowded market for haemophilia A therapies, and Bayer is hoping that the new products dosing schedule will prove popular with patients and physicians. ... and Eloctate, and CSL Behring’s Afstyla, uptake

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics